A
Affimed NV
AFMD
5.02000
USD
-0.05
(-0.99%)
مغلق
حجم التداول
662
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
49,708,038
الأخبار
العنوان: Affimed NV
القطاع: Healthcare
الصناعة: Biotechnology
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents anapproach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.